Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Site Validation of Ella Platform for Serum Nfl And GFAP Measures In Multiple Sclerosis Patients

NCT05352971 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Nīmes as lead sponsor.

NCT NCT05352971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05352971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Site Validation of Ella Platform for Serum Nfl And GFAP Measures In Multiple Sclerosis Patients
Lead sponsor
Centre Hospitalier Universitaire de Nīmes
Phase
Observational
Overall status
Completed
Start date
September 15, 2022
Completion date
September 30, 2023
Enrollment
664 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis